お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はエクソソーム市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはエクソソームの主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のエクソソーム市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはエクソソームのメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にエクソソーム市場を分類しています。本研究に含まれる主な企業は：Fujifilm、Thermo Fisher Scientific、Danaher、Illumina、Qiagen、Takara Bio、Malvern Instruments、Miltenyi Biotec、MBL International、Lonza

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Non-coding RNAs
    Lipids
    mRNA
    DNA fragments
    Proteins /peptides

用途別の市場セグメント：
    Cancer
    Infectious diseases
    Neurodegenerative diseases
    Cardiovascular diseases

本レポートの詳細内容
世界のエクソソーム市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、エクソソームタイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のエクソソーム収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のエクソソーム市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、エクソソーム市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

エクソソームのレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：エクソソームのレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：エクソソームの世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章エクソソーム企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：エクソソームの各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：エクソソームの主要企業の概要を提供し、製品の説明と仕様、エクソソームの収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Exosomes Market
The global Exosomes market is projected to grow from US$ 476.4 million in 2024 to US$ 1166.7 million by 2030, at a Compound Annual Growth Rate (CAGR) of 16.1% during the forecast period.
The US & Canada market for Exosomes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Exosomes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Exosomes is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Exosomes include Fujifilm, Thermo Fisher Scientific, Danaher, Illumina, Qiagen, Takara Bio, Malvern Instruments, Miltenyi Biotec and MBL International, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Exosomes is widely used in various fields, such as Cancer, Infectious diseases, Neurodegenerative diseases and Cardiovascular diseases, etc. Cancer provides greatest supports to the Exosomes industry development. In 2023, global % revenue of Exosomes went into Cancer filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Exosomes market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Exosomes, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Exosomes, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Exosomes revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Exosomes market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Exosomes revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Fujifilm, Thermo Fisher Scientific, Danaher, Illumina, Qiagen, Takara Bio, Malvern Instruments, Miltenyi Biotec and MBL International, etc.

Market Segmentation
By Company
    Fujifilm
    Thermo Fisher Scientific
    Danaher
    Illumina
    Qiagen
    Takara Bio
    Malvern Instruments
    Miltenyi Biotec
    MBL International
    Lonza

Segment by Type
    Non-coding RNAs
    Lipids
    mRNA
    DNA fragments
    Proteins /peptides

Segment by Application
    Cancer
    Infectious diseases
    Neurodegenerative diseases
    Cardiovascular diseases

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Exosomes in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Exosomes companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Exosomes revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Exosomes Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Non-coding RNAs
    Table 3. Key Players of Lipids
    Table 4. Key Players of mRNA
    Table 5. Key Players of DNA fragments
    Table 6. Key Players of Proteins /peptides
    Table 7. Global Exosomes Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 8. Global Exosomes Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 9. Global Exosomes Market Size by Region (2019-2024) & (US$ Million)
    Table 10. Global Exosomes Market Share by Region (2019-2024)
    Table 11. Global Exosomes Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 12. Global Exosomes Market Share by Region (2025-2030)
    Table 13. Exosomes Market Trends
    Table 14. Exosomes Market Drivers
    Table 15. Exosomes Market Challenges
    Table 16. Exosomes Market Restraints
    Table 17. Global Exosomes Revenue by Players (2019-2024) & (US$ Million)
    Table 18. Global Exosomes Revenue Share by Players (2019-2024)
    Table 19. Global Top Exosomes by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosomes as of 2023)
    Table 20. Global Exosomes Industry Ranking 2022 VS 2023 VS 2024
    Table 21. Global 5 Largest Players Market Share by Exosomes Revenue (CR5 and HHI) & (2019-2024)
    Table 22. Global Key Players of Exosomes, Headquarters and Area Served
    Table 23. Global Key Players of Exosomes, Product and Application
    Table 24. Global Key Players of Exosomes, Product and Application
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Exosomes Market Size by Type (2019-2024) & (US$ Million)
    Table 27. Global Exosomes Revenue Market Share by Type (2019-2024)
    Table 28. Global Exosomes Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 29. Global Exosomes Revenue Market Share by Type (2025-2030)
    Table 30. Global Exosomes Market Size by Application (2019-2024) & (US$ Million)
    Table 31. Global Exosomes Revenue Share by Application (2019-2024)
    Table 32. Global Exosomes Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 33. Global Exosomes Revenue Share by Application (2025-2030)
    Table 34. North America Exosomes Market Size by Type (2019-2024) & (US$ Million)
    Table 35. North America Exosomes Market Size by Type (2025-2030) & (US$ Million)
    Table 36. North America Exosomes Market Size by Application (2019-2024) & (US$ Million)
    Table 37. North America Exosomes Market Size by Application (2025-2030) & (US$ Million)
    Table 38. North America Exosomes Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 39. North America Exosomes Market Size by Country (2019-2024) & (US$ Million)
    Table 40. North America Exosomes Market Size by Country (2025-2030) & (US$ Million)
    Table 41. Europe Exosomes Market Size by Type (2019-2024) & (US$ Million)
    Table 42. Europe Exosomes Market Size by Type (2025-2030) & (US$ Million)
    Table 43. Europe Exosomes Market Size by Application (2019-2024) & (US$ Million)
    Table 44. Europe Exosomes Market Size by Application (2025-2030) & (US$ Million)
    Table 45. Europe Exosomes Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 46. Europe Exosomes Market Size by Country (2019-2024) & (US$ Million)
    Table 47. Europe Exosomes Market Size by Country (2025-2030) & (US$ Million)
    Table 48. China Exosomes Market Size by Type (2019-2024) & (US$ Million)
    Table 49. China Exosomes Market Size by Type (2025-2030) & (US$ Million)
    Table 50. China Exosomes Market Size by Application (2019-2024) & (US$ Million)
    Table 51. China Exosomes Market Size by Application (2025-2030) & (US$ Million)
    Table 52. Asia Exosomes Market Size by Type (2019-2024) & (US$ Million)
    Table 53. Asia Exosomes Market Size by Type (2025-2030) & (US$ Million)
    Table 54. Asia Exosomes Market Size by Application (2019-2024) & (US$ Million)
    Table 55. Asia Exosomes Market Size by Application (2025-2030) & (US$ Million)
    Table 56. Asia Exosomes Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 57. Asia Exosomes Market Size by Region (2019-2024) & (US$ Million)
    Table 58. Asia Exosomes Market Size by Region (2025-2030) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Exosomes Market Size by Type (2019-2024) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Exosomes Market Size by Type (2025-2030) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Exosomes Market Size by Application (2019-2024) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Exosomes Market Size by Application (2025-2030) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Exosomes Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 64. Middle East, Africa, and Latin America Exosomes Market Size by Country (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Exosomes Market Size by Country (2025-2030) & (US$ Million)
    Table 66. Fujifilm Company Details
    Table 67. Fujifilm Business Overview
    Table 68. Fujifilm Exosomes Product
    Table 69. Fujifilm Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 70. Fujifilm Recent Developments
    Table 71. Thermo Fisher Scientific Company Details
    Table 72. Thermo Fisher Scientific Business Overview
    Table 73. Thermo Fisher Scientific Exosomes Product
    Table 74. Thermo Fisher Scientific Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 75. Thermo Fisher Scientific Recent Developments
    Table 76. Danaher Company Details
    Table 77. Danaher Business Overview
    Table 78. Danaher Exosomes Product
    Table 79. Danaher Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 80. Danaher Recent Developments
    Table 81. Illumina Company Details
    Table 82. Illumina Business Overview
    Table 83. Illumina Exosomes Product
    Table 84. Illumina Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 85. Illumina Recent Developments
    Table 86. Qiagen Company Details
    Table 87. Qiagen Business Overview
    Table 88. Qiagen Exosomes Product
    Table 89. Qiagen Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 90. Qiagen Recent Developments
    Table 91. Takara Bio Company Details
    Table 92. Takara Bio Business Overview
    Table 93. Takara Bio Exosomes Product
    Table 94. Takara Bio Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 95. Takara Bio Recent Developments
    Table 96. Malvern Instruments Company Details
    Table 97. Malvern Instruments Business Overview
    Table 98. Malvern Instruments Exosomes Product
    Table 99. Malvern Instruments Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 100. Malvern Instruments Recent Developments
    Table 101. Miltenyi Biotec Company Details
    Table 102. Miltenyi Biotec Business Overview
    Table 103. Miltenyi Biotec Exosomes Product
    Table 104. Miltenyi Biotec Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 105. Miltenyi Biotec Recent Developments
    Table 106. MBL International Company Details
    Table 107. MBL International Business Overview
    Table 108. MBL International Exosomes Product
    Table 109. MBL International Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 110. MBL International Recent Developments
    Table 111. Lonza Company Details
    Table 112. Lonza Business Overview
    Table 113. Lonza Exosomes Product
    Table 114. Lonza Revenue in Exosomes Business (2019-2024) & (US$ Million)
    Table 115. Lonza Recent Developments
    Table 116. Research Programs/Design for This Report
    Table 117. Key Data Information from Secondary Sources
    Table 118. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Exosomes Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Exosomes Market Share by Type: 2023 VS 2030
    Figure 3. Non-coding RNAs Features
    Figure 4. Lipids Features
    Figure 5. mRNA Features
    Figure 6. DNA fragments Features
    Figure 7. Proteins /peptides Features
    Figure 8. Global Exosomes Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 9. Global Exosomes Market Share by Application: 2023 VS 2030
    Figure 10. Cancer Case Studies
    Figure 11. Infectious diseases Case Studies
    Figure 12. Neurodegenerative diseases Case Studies
    Figure 13. Cardiovascular diseases Case Studies
    Figure 14. Exosomes Report Years Considered
    Figure 15. Global Exosomes Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 16. Global Exosomes Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 17. Global Exosomes Market Share by Region: 2023 VS 2030
    Figure 18. Global Exosomes Market Share by Players in 2023
    Figure 19. Global Top Exosomes Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosomes as of 2023)
    Figure 20. The Top 10 and 5 Players Market Share by Exosomes Revenue in 2023
    Figure 21. North America Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. North America Exosomes Market Share by Type (2019-2030)
    Figure 23. North America Exosomes Market Share by Application (2019-2030)
    Figure 24. North America Exosomes Market Share by Country (2019-2030)
    Figure 25. United States Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Canada Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Europe Exosomes Market Size YoY (2019-2030) & (US$ Million)
    Figure 28. Europe Exosomes Market Share by Type (2019-2030)
    Figure 29. Europe Exosomes Market Share by Application (2019-2030)
    Figure 30. Europe Exosomes Market Share by Country (2019-2030)
    Figure 31. Germany Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. France Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. U.K. Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Italy Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Russia Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Nordic Countries Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. China Exosomes Market Size YoY (2019-2030) & (US$ Million)
    Figure 38. China Exosomes Market Share by Type (2019-2030)
    Figure 39. China Exosomes Market Share by Application (2019-2030)
    Figure 40. Asia Exosomes Market Size YoY (2019-2030) & (US$ Million)
    Figure 41. Asia Exosomes Market Share by Type (2019-2030)
    Figure 42. Asia Exosomes Market Share by Application (2019-2030)
    Figure 43. Asia Exosomes Market Share by Region (2019-2030)
    Figure 44. Japan Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. South Korea Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. China Taiwan Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. Southeast Asia Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. India Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Australia Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Exosomes Market Size YoY (2019-2030) & (US$ Million)
    Figure 51. Middle East, Africa, and Latin America Exosomes Market Share by Type (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Exosomes Market Share by Application (2019-2030)
    Figure 53. Middle East, Africa, and Latin America Exosomes Market Share by Country (2019-2030)
    Figure 54. Brazil Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Mexico Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Turkey Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Saudi Arabia Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Israel Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. GCC Countries Exosomes Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Fujifilm Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 61. Thermo Fisher Scientific Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 62. Danaher Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 63. Illumina Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 64. Qiagen Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 65. Takara Bio Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 66. Malvern Instruments Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 67. Miltenyi Biotec Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 68. MBL International Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 69. Lonza Revenue Growth Rate in Exosomes Business (2019-2024)
    Figure 70. Bottom-up and Top-down Approaches for This Report
    Figure 71. Data Triangulation
    Figure 72. Key Executives Interviewed